1 |
Heit, M. C., Riviere, J. E., 1997. Electrically-Assisted transdermal drug delivery. Pharmceutical Research. 14(6), 687-761.
DOI
|
2 |
Merino, V., Lopez, A., Kalia, Y.N., Guy, R.H., 1999. Electrorepulsion versus electroosmosis : effect of pH on the iontophoresis flux of 5-fluorouracil. Pharm. Res. 16(5), 758-761.
DOI
|
3 |
Bommannan, B., Potts, R.O., Guy, R., 1991. Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy. J. Controlled Release. 16(3), 299-304.
DOI
|
4 |
Hirvonen, J., Guy, R.H., 1998. Transdermal iontophoresis: modulation of electroosmosis by polypeptides. J. Controlled Release. 50(1-3), 283-289.
DOI
|
5 |
Hirvonen, J., Guy, R.H., 1997. Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances. Pharm. Res. 14, 1258-1263.
DOI
|
6 |
Oh, S.Y., 2004. Transdermal delivery of ketoprofen and the effect of electroosmosis. J. Kor. Pharm. Sci. 34(6), 491-497.
과학기술학회마을
DOI
|
7 |
Sieg, A., Guy, R.H., Delgado-Charro, M.B., 2004. Noninvasive glucose monitoring by reverse iontophoresis in vivo: application of the internal standard concept. Clin. Chem. 50(8), 1383-1390.
DOI
|
8 |
Bath, B.D., White, H.S., Scott, E.R., 2000. Visualization and analysis of electroosmotic flow in hairless mouse skin. Pharm. Res. 17, 471-475.
DOI
|
9 |
Marro, D., Guy, R.H., Delgado-Charro, M.B., 2001. Characterization of the iontophoretic permselectivity properties of human and pig skin. J. Contr. Rel. 70, 213-217.
DOI
|
10 |
Oda, Y., Ohe, H., Asakawa, N., Yoshida, Y., Sato, T., 1992. Resolution of 1-benzyl-4-[(5, 6-dimethoxy-1-indanon)-2-yl] methylpiperidine hydrochloride enantiomers in plasma by highperformance liquid chromatography with direct injection into avidin-conjugated column. J. Liq. Chromatogr. 15, 2997-3012.
DOI
|
11 |
Choi, Y.R., Oh, S. Y., 2010. Electrotransport of Donepezil Hydrochloride from Poly(ethylene oxide) Hydrogel. J. Kor. Pharm. Sci. 40(2), 91-100.
과학기술학회마을
DOI
|
12 |
Avdeef, A., 2007. Solubility of sparingly-soluble ionizable drugs. Adv. Drug. Deliv. Rev. 59, 568-590.
DOI
|
13 |
Ahad, A., Aqil, M., Kohli, K., Chaudhary, H., Sultana, Y., Mujeeb, M., Talegaonkar, S., 2009. Chemical penetration enhancers: a patent review. Expert Opin. Ther. Pat. 19(7), 969-988.
DOI
|
14 |
Koizumi, A., Fujii, M., Kondoh , M., Watanabe, Y., 2004. Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. Eur. J. Pharmaceutics. 57(3), 473-478.
|
15 |
Barry, B.W., 1987. Mode of action of penetration enhancers in human skin. J. Controlled Rel. 6(1), 85-97.
DOI
|
16 |
Williams, A.C., Barry, B.W., 2004. Advanced Drug Delivery Reviews. 56, 603-618.
DOI
|
17 |
Pershing, L.K., Lambert, L.D., Knutson, K., 1990. Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo. Pharm. Res. 7, 170-175.
DOI
|
18 |
Yum,S.I., 1994. Permeation enhancement with ethanol. In: drug permeation enhancement. Marcel Dekker. New York.
|
19 |
Megrab, N.A., Williams, A.C., Barry, B.W., 1995. Oestradiol permeation across human skin, silastic and snake skin membranes: the effects of ethanol/water co-solvent systems. Int. J. Pharm. 116, 101-112.
DOI
|
20 |
Crismon, M.L., 1998. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease. Pharmacotherapy. 18(2), 47-54.
|
21 |
Kishnani, P.S., Sullivan, J.A., Walter, B.K., Spiridigliozzi, G.A., Doraiswamy, P.M., Krishnan, K.R., 1999. Cholinergic therapy for Down's syndrome. Lancet. 353(9158), 1064-1065.
DOI
|
22 |
Rogers, S.L., Friedhoff, L.T., 1996. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group. Dementia. 7(6), 293-303.
|
23 |
Subedi, R. K., Oh, S. Y., Chun, M. K., Choi, H. K., 2010. Recent advances in transdermal drug delivery. Arch. Pharm. Res. 33(3), 339-351.
DOI
|
24 |
Winblad, B., Cummings, J., Andreasen, N., Grossberg , G., Onofrj, M., Sadowsky, C., Zechner, S., Nagel, J., Lane, R., 2007. A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's diseaserivastigmine patch versus capsule. Int. J. Geriatr. Psychiatry. 22(5), 456- 467.
DOI
|
25 |
FDA Issues Complete Response Letter for Patch (donepezil transdermal system), http://www.health.netsimpler.com/ fda-issues-complete-response-letter-for-aricept%C2%AE-patchdonepezil- transdermal-system/, April 25, 2011.
|
26 |
Yan, G., Li, S.K., Higuchi, W.I., 2005. Evaluation of constant current alternating current iontophoresis for transdermal drug delivery. J. Control Release. 110(1), 141-150.,
DOI
|
27 |
Leboulanger, B., Guy, R. H., Delgado-Charro, M. B., 2004. Reverse iontophoresis for non-invasive transdermal monitoring. Physiol. Meas. 25(3), R35-R50.
DOI
|
28 |
Jann, M.W., Shirley, K.L., Small, G.W., 2002. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors. Clin. Pharmacokinet. 41, 719-739.
DOI
|
29 |
Lesne, S., Koh, M.T., Kotilinek, L., Kayed, R., Glabe, C.G., Yang, A., Gallagher, M., Ashe, K.H., 2006. A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 440, 352-357.
DOI
ScienceOn
|
30 |
Zhao, C., Deng, W., Gage, F.H., 2008. Mechanisms and functional implications of adult neurogenesis. Cell. 132(4), 645-660.
|
31 |
Lleo, A., Greenberg, S.M., Growdon , J.H., 2006. Current pharmacotherapy for Alzheimer's disease. Annu. Rev. Med. 57, 513-533.
DOI
|
32 |
Cummings, J., Winblad, B., 2007. A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia. Expert Rev. Neurother. 7(11), 1457-1463.
DOI
|
33 |
Olivares, D., Deshpande, V.K., Shi, Y., Lahiri, D.K., Greig, N.H., Rogers, J.T., Huang, X., 2011. N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer's Disease, Vascular Dementia and Parkinson's Disease. Curr. Alzheimer Res. Aug 30.
|
34 |
Tariot, P.N., Farlow, M.R., Grossberg, G.T., Graham, S.M., McDonald, S., Gergel, I., 2004. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. A randomized placebo controlled trial. Journal of the American Medical Association. 291, 317-324.
DOI
|
35 |
Nakano, S., Asada , T., Matsuda, H., Uno, M., Takasaki, M., 2001. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease. J. Nuclear. Med., 42(10), 1441-1445
|
36 |
Tiseo, P. J., Perdomo, C. A., Friedhoff, L. T., 1998. Metabolism and elimination of 14C-donepezil in healthy volunteers: a single- dose study. Br. J. Clin. Pharmacol. 46(S1), 19-24.
|
37 |
England, E., 2006. Improving the management of dementia. BMJ. 332, 681-682.
DOI
|
38 |
Physician's Desk Reference. 53th ed, 1999. Medical Economics Company, Montvale, NJ, pp. 2364-2367.
|
39 |
Jhoo, J.H., Kim, K.W., Huh, Y., Lee, S.B., Park, J.H., Lee, J.J., Choi, E.A., Han, C., Choo, I.H., Youn, J.C., Lee, D.Y., Woo, J.I., 2008. Prevalence of dementia and its subtypes in an elderly urban korean population: results from the Korean Longitudinal Study on Health And Aging (KLoSHA). Dement. Geriatr. Cogn. Disord. 26(3), 270-276.
|
40 |
Brookmeyer, R., Johnson, E., Ziegler-Graham, K., Arrighi, H.M., 2007. Forecasting the global burden of Alzheimer's disease. Alzheimers. Dement. 3(3), 186-191.
DOI
|
41 |
Querfurth, H.W., LaFerla, F.M., 2010. Alzheimer's disease. N. Engl. J. Med. 362(4), 329-344.
DOI
|
42 |
Scarpini, E., Scheltens, P., Feldman, H., 2003. Treatment of Alzheimer's disease: current status and new perspectives. Lancet. Neurol. 2, 539-547.
DOI
|
43 |
Francis, P.T., Palmer, A.M., Snape, M., Wilcock, G.K., 1999. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry. 66(2), 137-47.
DOI
|